---
schema_version: "secwatch.filing_event.v1"
accession: "0000019584-26-000002"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:29:18.611438+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Chemed Q4 2025 GAAP EPS down 9%, Roto-Rooter segment weak; guidance for 2026 growth

## Summary
- Revenue $639.3M flat YoY; GAAP diluted EPS $5.48 (-9%), adjusted EPS $6.42 (-6%).
- VITAS revenue +1.9% to $418.8M, ADC +1.3% to 22,462, admissions +6%.
- Roto-Rooter revenue -3.7% to $220.6M; adjusted EBITDA -21.1%, margin -477bps to 21.5%.
- Repurchased 400,000 shares for $174.6M at avg $436.39; $127.3M remaining authorization.
- FY2026 adjusted EPS guidance $23.25-$24.25 vs FY2025 $21.55; weighted to H2.

## SEC filing metadata
- accession: 0000019584-26-000002
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000001958426000002/0000019584-26-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000001958426000002/che-20260225x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000019584-26-000002
- JSON: https://secwatch.observer/filing/0000019584-26-000002.json
- Plain text: https://secwatch.observer/filing/0000019584-26-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.